Overall Survival with Amivantamab–Lazertinib in EGFR-Mutated Advanced NSCLC

Journal:

The New England Journal of Medicine

Published:

2025-09-08

DOI:

10.1056/nejmoa2503001

Affiliations:

52

Authors:

56

Go to article

Institutions	Authors	Share
Johnson & Johnson, United States of America (USA)	14.000000 14.000000	0.25
IRCCS European Institute of Oncology (IEO), Italy	2.000000	0.04
Faculty of Medicine Siriraj Hospital, MU, Thailand	1.000000	0.02
Medical Center in Kolomenskoye, Russia	1.000000	0.02
British Hospital, Argentina	1.000000	0.02
Health Pharma Professional Research, Mexico	1.000000	0.02
Institute Gustave-Roussy (IGR), France	1.000000	0.02
National Cancer Institute, Ukraine	1.000000	0.02
Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto), Portugal	1.000000	0.02
University of California, Irvine (UCI), United States of America (USA)	1.000000	0.02
City of Hope, United States of America (USA)	1.000000	0.02
Samsung Medical Center (SMC), South Korea	1.000000	0.02
Shanghai Chest Hospital, SJTU, China	1.000000	0.02
Henry Ford Health System (HFHS), United States of America (USA)	1.000000	0.02
Hospital Regional Universitario de Málaga, Spain	1.000000	0.02
Chungbuk National University Hospital, South Korea	1.000000	0.02
Asan Medical Center (AMC), South Korea	1.000000	0.02
IIUM Medical Centre, Malaysia	1.000000	0.02
Virginia Cancer Specialists (VCS), United States of America (USA)	1.000000	0.02
Seoul National University Bundang Hospital (SNUBH), South Korea	1.000000	0.02
St John of God Murdoch Hospital, Australia	1.000000	0.02
Barretos Cancer Hospital, Brazil	1.000000	0.02
Kindai University, Japan	1.000000	0.02
McGill University Health Centre (MUHC), Canada	1.000000	0.02
Santa Maria delle Croci Hospital, Italy	1.000000	0.02
Jilin Province Cancer Hospital, China	1.000000	0.02
Kansai Medical University Hospital, Japan	1.000000	0.02
Chung Shan Medical University Hospital, Taiwan	1.000000	0.02
National Taiwan University Hospital (NTUH), Taiwan	1.000000	0.02
Huizhou Municipal Central Hospital, China	1.000000	0.02
Moscow City Oncology Hospital No 62, Russia	1.000000	0.02
University of Malaya (UM), Malaysia	1.000000	0.02
Harbin Medical University Cancer Hospital, China	1.000000	0.02
Yonsei Cancer Hospital, South Korea	1.000000	0.02
Gazi University, Turkey	1.000000	0.02
Tata Memorial Hospital (TMH), TMC, India	1.000000	0.02
Ankara Bilkent City Hospital, Turkey	0.500000	0.01
Yıldırım Beyazıt University (YBU), Turkey	0.500000	0.01
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.500000	0.01
Autonomous University of Barcelona (UAB), Spain	0.500000	0.01
Hospital Civil de Guadalajara, Mexico	0.500000	0.01
University of Guadalajara (UDG), Mexico	0.500000	0.01
University of Versailles Saint-Quentin-en-Yvelines (UVSQ), France	0.500000	0.01
Curie Institute, France	0.500000	0.01
The Christie NHS Foundation Trust, United Kingdom (UK)	0.500000	0.01
The University of Manchester (UoM), United Kingdom (UK)	0.500000	0.01
Translational Lung Research Center Heidelberg (TLRC), Germany	0.333333	0.01
National Center for Tumor Diseases (NCT) Heidelberg, Germany	0.333333	0.01
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany	0.333333	0.01

Interested in Oncology and Carcinogenesis?